Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin Study
NCT02227446Phase 3Completed
- Sponsor
- Major Extremity Trauma Research Consortium
- Start
- Oct 2014
- Primary completion
- Jun 2018
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vancomycin in surgical site infection (SSI), sponsored by Major Extremity Trauma Research Consortium. Started Oct 2014; status: completed.
02
Drugs
vancomycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT02227446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02227446.